Growth Metrics

Quest Diagnostics (DGX) Gains from Investment Securities (2016 - 2026)

Quest Diagnostics has reported Gains from Investment Securities over the past 18 years, most recently at $37.0 million for Q1 2026.

  • Quarterly Gains from Investment Securities rose 3600.0% to $37.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $81.0 million through Mar 2026, up 3950.0% year-over-year, with the annual reading at $45.0 million for FY2025, 87.5% up from the prior year.
  • Gains from Investment Securities was $37.0 million for Q1 2026 at Quest Diagnostics, up from $25.0 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $55.0 million in Q3 2024 and troughed at -$60.0 million in Q2 2022.
  • The 5-year median for Gains from Investment Securities is $3.0 million (2023), against an average of $4.5 million.
  • Biggest five-year swings in Gains from Investment Securities: crashed 1900.0% in 2024 and later skyrocketed 3600.0% in 2026.
  • Tracing DGX's Gains from Investment Securities over 5 years: stood at -$29.0 million in 2022, then soared by 196.55% to $28.0 million in 2023, then soared by 96.43% to $55.0 million in 2024, then crashed by 54.55% to $25.0 million in 2025, then soared by 48.0% to $37.0 million in 2026.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $37.0 million, $25.0 million, and -$22.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.